SAN FRANCISCO, Jan. 8, 2018 /PRNewswire/ -- ResMed
(NYSE: RMD, ASX: RMD) today introduced Mobi, its first
ResMed-branded portable oxygen concentrator (POC).
Mobi offers an industry-leading balance of oxygen delivery,
weight and battery life so that millions with chronic obstructive
pulmonary disease (COPD) or other respiratory condition can enjoy
ResMed-quality oxygen therapy at home or on the go.
"We have focused decades of patient-centered ResMed technology
and design innovation into this POC," said ResMed CEO Mick Farrell. "We've achieved great mobility,
comfort and therapy quality in sleep apnea treatment with AirMini,
the world's smallest PAP device. Mobi offers that same great
balance to the many millions of people who rely on supplemental
oxygen to enjoy their highest quality of life."
Mobility is particularly key for oxygen patients with chronic
obstructive pulmonary disease. Regular physical activity is shown
to lower the risk of hospitalization and death among those with
COPD, according to a 2006 study published in Thorax:
http://thorax.bmj.com/content/61/9/772.
"The time is now for portable oxygen," said Farrell. "Our
patients demand a device that enables them to get out of their
house and travel to visit friends and family. Mobi gives the gift
of freedom to millions."
Availability
Mobi will be available to U.S. patients through their home
medical equipment (HME) providers later this quarter. ResMed
is pursuing clearance to sell in other countries in 2018.
About ResMed
ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health
company with more than 4 million cloud-connected devices for daily
remote patient monitoring, changes lives with every breath. Its
award-winning devices and software solutions help treat and manage
sleep apnea, chronic obstructive pulmonary disease and other
respiratory conditions. Its 6,000-member team strives to improve
patients' quality of life, reduce the impact of chronic disease and
save healthcare costs in more than 120 countries. ResMed.com
For
media:
|
For
investors:
|
Jayme
Rubenstein
|
Agnes
Lee
|
+1
858-836-6798
|
+1
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/resmed-announces-its-premier-portable-oxygen-concentrator-mobi-300578384.html
SOURCE ResMed Inc.